InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,473.17
(
-0.25%
)
US TECH 100
19,268.80
(
0.05%
)
Dow Jones
39,134.76
(
0.77%
)
Brent Oil
84.94
(
-0.08%
)
Bitcoin
63,931.28
(
-1.37%
)
Post# of 252279
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 834
Posts 119885
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: biomaven0 post# 121891

Saturday, 06/18/2011 11:33:58 PM

Saturday, June 18, 2011 11:33:58 PM

Post# of 252279
Re: Handicapping the Copaxone patent case

I still think the lack of enablement/best mode/insufficient disclosure constellation might prove to be the strongest arguments.

Feel free to put some numeric probabilities out there for the rest of us to criticize :- ) exwannabe did it in #msg-59693896, I did it in #msg-59688565, and zipjet sort of did it in #msg-56326587. Regards, Dew

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up